Tevogen TVGN
NASDAQ TVGN
$7.29 -0.05 (-0.68%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tevogen (TVGN) Total Debt (2023 - 2026)

Tevogen's (TVGN) quarterly Total Debt came in at $6.4 million in Q2 2026, up 5.77% on a YoY basis from $6.1 million in Q2 2025, and down 20.51% quarter-over-quarter from $8.1 million in Q1 2026.

Analysis

Tevogen (TVGN) Total Debt (2023 - 2026) Analysis & Trends

Tevogen (TVGN) has reported Total Debt for 4 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Debt rose 5.77% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2026 stood at $6.4 million (up 5.77% YoY), and the FY2025 full-year result was $6.1 million, up 128.25% from the prior year.
  • Total Debt retreated to $6.4 million in Q2 2026 per TVGN's latest filing, from $8.1 million in the prior quarter.
  • Across five years, Total Debt topped out at $80.7 million in Q4 2023 and bottomed at $625694.0 in Q2 2023.
  • Historically, Total Debt has averaged $9.8 million across 4 years, with a median of $4.7 million in 2025.
  • The widest YoY moves for Total Debt: up 325.68% in 2024, down 96.72% in 2024.
  • Over 4 years, Total Debt stood at $80.7 million in 2023, then sank by 96.72% to $2.7 million in 2024, then soared by 128.25% to $6.1 million in 2025, then gained by 5.77% to $6.4 million in 2026.
  • According to Business Quant data, Total Debt over the past three periods registered $6.4 million, $8.1 million, and $6.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 586.20 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn -
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 156.40 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 50.15 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 112.43 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 93.88 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 847.62 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Tevogen 27.76 Mn 27.76 Mn - 6.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.40 Mn
Mar 31, 2026 8.05 Mn
Dec 31, 2025 6.05 Mn
Sep 30, 2025 6.05 Mn
Jun 30, 2025 6.05 Mn
Mar 31, 2025 4.65 Mn
Dec 31, 2024 2.65 Mn
Sep 30, 2024 2.66 Mn
Jun 30, 2024 1.65 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 80.71 Mn
Sep 30, 2023 625,694.00
Jun 30, 2023 625,694.00